.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Medtronic
QuintilesIMS
Novartis
US Department of Justice
Cipla
Express Scripts
Julphar
Cerilliant
Federal Trade Commission

Generated: June 29, 2017

DrugPatentWatch Database Preview

Tromethamine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for tromethamine and what is the scope of tromethamine freedom to operate?

Tromethamine
is the generic ingredient in one branded drug marketed by Hospira and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for tromethamine. One supplier is listed for this compound.

Summary for Generic Name: tromethamine

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list26
Suppliers / Packagers: see list1
Bulk Api Vendors: see list154
Clinical Trials: see list63
Patent Applications: see list95,016
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:tromethamine at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
THAM
tromethamine
INJECTABLE;INJECTION013025-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Merck
Boehringer Ingelheim
Baxter
Citi
Covington
Harvard Business School
Julphar
Moodys
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot